BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 29, 2019
View Archived Issues
Glial dysfunction is part of chemo brain
Read More
TLRs in DIO
Read More
"R-AI-diologist" can outperform radiologists in lung cancer screening
Read More
In infection, T cells are cachexia drivers
Read More
Food antigens drive IgE antibody elevation if no commensals present
Read More
SNG-001 for virus-induced exacerbations of lung disease
Read More
Enrollment opens in phase III study of HLX-10 in esophageal squamous cell carcinoma
Read More
Soligenix obtains support to study IDRs as bacterial threat countermeasures
Read More
Mutation in mevalonate kinase found in porokeratosis ptychotropica
Read More
Integral Molecular achieves milestone in Daiichi Sankyo immuno-oncology collaboration
Read More
Ziopharm and NCI sign T-cell technology licensing agreement
Read More
Bristol-Myers Squibb patents farnesoid X receptor agonists
Read More
ProMIS identifies antibody candidates that selectively bind toxic oligomers of tau for Alzheimer's
Read More
Researchers develop new murine model of dystrophic epidermolysis bullosa-squamous cell carcinoma
Read More
AbbVie and Calico Life Sciences jointly describe EIF2B activators
Read More
Idorsia prepares and tests antibacterial compounds
Read More
P2X3 and/or P2X2/3 receptor antagonists described in Beijing Tide Pharmaceutical patent
Read More
AiCuris reports agents for the treatment of HBV infections
Read More
In vivo antitumoral activity seen with mixture of cytokine-encoding mRNAs
Read More
FDA approves Revlimid with rituximab for previously treated FL and marginal zone lymphoma
Read More
Zynerba initiates phase II trial of Zygel to treat behavioral symptoms in 22q11.2 deletion syndrome
Read More
Eli Lilly divulges BTK inhibitors in recent patent
Read More